ACM
KURA icon

AlphaCrest Capital Management’s Kura Oncology KURA Stock Holding History

AlphaCrest Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,375
Closed -$606K – 615
2022
Q3 		$606K Buy
44,375
+25,970
+141% +$401K 0.04% 891
2022
Q2 		$337K Sell
18,405
-9,101
-33% -$131K 0.02% 1081
2022
Q1 		$442K Sell
27,506
-31,675
-54% -$457K 0.02% 953
2021
Q4 		$829K Buy
59,181
+46,081
+352% +$747K 0.03% 883
2021
Q3 		$245K Sell
13,100
-53,200
-80% -$1M 0.01% 1166
2021
Q2 		$1.38M Buy
66,300
+38,800
+141% +$963K 0.06% 508
2021
Q1 		$777K Buy
+27,500
New +$870K 0.04% 604

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

AlphaCrest Capital Management's KURA Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Kura Oncology (KURA) in Q4 2022, closing a stake of 44,375 shares — an estimated $606K sold.

AlphaCrest Capital Management first reported a position in KURA in Q1 2021 and held it in 7 quarters. The position peaked at $1.38M in Q2 2021. 142 funds tracked by Wall St. Rank hold KURA as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Kura Oncology position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 44,375 Kura Oncology shares in Q4 2022, an estimated $606K.
  • AlphaCrest Capital Management first reported a position in Kura Oncology in Q1 2021 and held it in 7 quarters.
  • AlphaCrest Capital Management's Kura Oncology position peaked at $1.38M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.